Stephen Salton, MD, PhD
Stephen R. Salton, MD, PhD, attended the University of Pennsylvania, graduating with magna cum laude honors in biochemistry; completed the MD-PhD program at New York University; and, following an internship and residency in internal medicine at Bellevue Hospital in New York, conducted postdoctoral research in molecular neuroendocrinology at Columbia University College of Physicians and Surgeons and Mount Sinai School of Medicine. Dr. Salton has received a number of academic and scientific honors including a Medical Scientist Training Program Award, Pfizer Post-Doctoral and Scholar Awards, Pew Scholars Award in the Biomedical Sciences, Irma T. Hirschl-Monique Weill-Caulier Career Scientist Award, and NARSAD van Ameringen Investigator Award. He has held faculty positions at the Icahn School of Medicine at Mount Sinai since 1989, and currently is a tenured professor in the Departments of Neuroscience and Geriatrics. Dr. Salton’s molecular neurobiology lab investigates the mechanisms mediating neurotrophic growth factor regulation of neural development and nervous system function, impacting the understanding of depression, memory, body weight control, neuropathic pain, and neurodegeneration. He additionally plays an active role in the broader educational mission of the institution, and contributes to a number of committees at Mount Sinai that oversee its academic and teaching missions. Dr. Salton has been co-director of the Neuroscience Graduate Training Area, responsible for overseeing the administration and operation of the program since 2000. He is author of the application securing Mount Sinai’s neuroscience PhD granting program that was approved in 2007 by NYU and the New York State Education Department. Dr. Salton currently is principal investigator on two National Institutes of Health-supported T32 training programs.